TapewireFind a company

person · Reporting owner

Martin Sarah Rachel

Disclosed activity across 1 company

Tapewire entity
67798
SEC CIK
0002065871

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
LENNOX INTERNATIONAL INCLII · Entity 3415EVP & Pres., Home Comfort SolFebruary 02, 2026February 04, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

LENNOX INTERNATIONAL INC

Report date February 02, 2026 · Filed February 04, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common Stock, Par Value $0.01 Per ShareSEC Table I · non-derivativeDirect2,355 Reported balance After 2026-02-02 transaction · row 1
1 source row

Row 1 · 2026-02-02 · Grant · Acquired 708 · Balance 2,355

Non-qualified Stock Appreciation RightSEC Table II · derivative / convertible security · Conversion / exercise price $493.09 · Expires 2033-02-02Direct1,705 Reported balance After 2026-02-02 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2026-02-02 · Grant · Acquired 1,705 · Balance 1,705

F1: One third of the Stock Appreciation Rights will become exercisable on 02/02/2027 and each year thereafter. The entire grant will become fully exercisable on 02/02/2029.

Filing footnotes · ownership attribution and instrument terms

F1: One third of the Stock Appreciation Rights will become exercisable on 02/02/2027 and each year thereafter. The entire grant will become fully exercisable on 02/02/2029.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
February 02, 2026 Filed Feb 4, 2026 21:06 UTC LENNOX INTERNATIONAL INC LII · Entity 3415 GrantNon-qualified Stock Appreciation Right · Derivative 1,705 $0.00 Strike: $493.09 $0.00
Disclosure

SEC source: 0001069202-26-000011 · form4.xml · derivative · entry 2

Martin Sarah Rachel · CIK 0002065871 · EVP & Pres., Home Comfort Sol

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,705

Underlying: Common Stock, Par Value $0.01 Per Share · 1,705 shares

Expires 2033-02-02

F1 · derivative.exercise_date: One third of the Stock Appreciation Rights will become exercisable on 02/02/2027 and each year thereafter. The entire grant will become fully exercisable on 02/02/2029.

Read SEC document
February 02, 2026 Filed Feb 4, 2026 21:06 UTC LENNOX INTERNATIONAL INC LII · Entity 3415 GrantCommon Stock, Par Value $0.01 Per Share 708 $0.00 $0.00
Disclosure

SEC source: 0001069202-26-000011 · form4.xml · nonDerivative · entry 1

Martin Sarah Rachel · CIK 0002065871 · EVP & Pres., Home Comfort Sol

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,355

Read SEC document
April 28, 2025 Filed Apr 29, 2025 21:00 UTC LENNOX INTERNATIONAL INC LII · Entity 3415 GrantCommon Stock, Par Value $0.01 Per Share 1,647 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-012755 · form4.xml · nonDerivative · entry 1

Martin Sarah Rachel · CIK 0002065871 · EVP & Pres., Home Comfort Sol

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,647

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.